WHO ICTRP trial
study of water soluble extract of Shalaparni and Bhringaraja for the treatment…
CTRI/2017/12/010843 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2017/12/010843 |
|---|---|
| Public title | study of water soluble extract of Shalaparni and Bhringaraja for the treatment of Essential Hypertension â?? |
| Scientific title | â??Clinical efficacy of aqueous extract of Shalaparni (Desmodium gangeticum) and Bhringaraja (Eclipta alba) in the management of Essential Hypertension (Vyanabala Vaishamya)â?? |
| Primary sponsor | National institute of Ayurveda |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: null- Diagnosed stage-2 Essential Hypertension having no known complications of disease |
| Interventions | Intervention1: Shalaparni (Desmodium gangeticum): aqueous extract of Shalaparni (Desmodium gangeticum) Capsule500 mg BD for 1 month. Intervention2: Bhringaraja (Eclipta alba): aqueous extract of Bhringaraja (Eclipta alba) Capsule500 mg BD… |
| Registration date | Dec 12, 2017 |
| Target size | 45 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: